Pfizer

PFE · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.908%

12M weight contribution

+0.045 pp

3M weight contribution

-0.163 pp

12M price return

+1.4%

Share of matched S&P 500 members

Monthly observations through Aug 2022

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Aug 2022	$253.8bn	0.908%	+0.045 pp	+1.4%	No
Jul 2022	$283.4bn	0.974%	+0.152 pp	+21.8%	No
Jun 2022	$294.2bn	1.144%	+0.370 pp	+38.4%	Yes
May 2022	$297.6bn	1.072%	+0.295 pp	+41.6%	Yes
Apr 2022	$275.9bn	0.998%	+0.216 pp	+31.5%	Yes
Mar 2022	$291.1bn	0.980%	+0.585 pp	+48.0%	Yes
Feb 2022	$264.0bn	0.916%	+0.542 pp	+45.2%	No
Jan 2022	$295.7bn	0.995%	+0.517 pp	+52.0%	Yes
Dec 2021	$331.4bn	1.062%	+0.234 pp	+66.7%	Yes
Nov 2021	$301.6bn	1.019%	+0.115 pp	+45.7%	Yes
Oct 2021	$245.2bn	0.819%	-0.066 pp	+35.2%	Yes
Sep 2021	$241.1bn	0.847%	+0.846 pp	+28.5%	Yes
Aug 2021	$258.3bn	0.864%	+0.863 pp	+33.7%	Yes
Jul 2021	$239.6bn	0.822%	+0.821 pp	+22.0%	Yes
Jun 2021	$219.2bn	0.774%	+0.773 pp	+31.4%	Yes
May 2021	$216.8bn	0.777%	+0.776 pp	+11.3%	Yes
Apr 2021	$215.6bn	0.781%	-0.349 pp	+10.6%	Yes
Mar 2021	$202.1bn	0.395%	+0.394 pp	+21.9%	No
Feb 2021	$186.8bn	0.373%	+0.373 pp	+10.0%	No
Jan 2021	$199.5bn	0.478%	-0.487 pp	+5.8%	No
Dec 2020	$204.6bn	0.828%	-0.181 pp	+3.1%	Yes
Nov 2020	$212.9bn	0.904%	-0.115 pp	+9.1%	Yes
Oct 2020	$187.1bn	0.886%	-0.164 pp	-3.8%	Yes
Sep 2020	$193.5bn	0.001%	-1.001 pp	+6.3%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.